|
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
RECRUITINGN/ASponsored by Virginia Commonwealth University
Actively Recruiting
PhaseN/A
SponsorVirginia Commonwealth University
Started2021-03-01
Est. completion2026-02-28
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT05334732
Summary
The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Eligibility
Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Self-identify as Black * Newly diagnosed (\~4 weeks post-definitive surgery and prior to initiation of adjuvant chemotherapy or endocrine therapy) patients (stage I-III) * Eligible for chemotherapy or endocrine therapy according to NCCN guidelines, but have not initiated systemic therapy * Ability to read and speak English * Ability to provide meaningful consent as determined by trained study personnel and/or a member of the patient's care team * No prior cancer treatment (other than skin cancer) in the two years preceding enrollment * Physicians Must be a license doctor of study patient(s) * Ability to speak English
Conditions2
Breast CancerCancer
Locations3 sites
District of Columbia
2 sitesMedstar Georgetown University Hospital
Washington D.C., District of Columbia, 20007
Hurtado de Mendozaahd28@georgetown.edu
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010
Virginia
1 siteMassey Cancer Center
Richmond, Virginia, 23298
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorVirginia Commonwealth University
Started2021-03-01
Est. completion2026-02-28
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT05334732